Lamendola C[au] - Search Results

Year	Number of Results
1989	1
1990	2
1992	1
1993	1
1996	1
1999	4
2000	5
2001	6
2002	7
2003	5
2004	7
2005	4
2006	5
2007	8
2008	7
2009	8
2010	5
2011	4
2012	1
2013	3
2014	6
2015	6
2016	2
2017	2
2018	3
2019	1
2020	1
2021	0

1

Risk factors for type 2 diabetes mellitus.

Fletcher B, Gulanick M, Lamendola C. Fletcher B, et al. Among authors: lamendola c. J Cardiovasc Nurs. 2002 Jan;16(2):17-23. doi: 10.1097/00005082-200201000-00003. J Cardiovasc Nurs. 2002. PMID: 11800065 Review.

2

T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans.

McLaughlin T, Liu LF, Lamendola C, Shen L, Morton J, Rivas H, Winer D, Tolentino L, Choi O, Zhang H, Hui Yen Chng M, Engleman E. McLaughlin T, et al. Among authors: lamendola c. Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2637-43. doi: 10.1161/ATVBAHA.114.304636. Epub 2014 Oct 23. Arterioscler Thromb Vasc Biol. 2014. PMID: 25341798 Free PMC article. Clinical Trial.

3

Insulin resistance syndrome.

Fletcher B, Lamendola C. Fletcher B, et al. Among authors: lamendola c. J Cardiovasc Nurs. 2004 Sep-Oct;19(5):339-45. doi: 10.1097/00005082-200409000-00009. J Cardiovasc Nurs. 2004. PMID: 15495894 Review.

4

Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9-39) for treatment of post-bariatric hypoglycaemia.

Tan M, Lamendola C, Luong R, McLaughlin T, Craig C. Tan M, et al. Among authors: lamendola c. Diabetes Obes Metab. 2020 Aug;22(8):1406-1416. doi: 10.1111/dom.14048. Epub 2020 May 4. Diabetes Obes Metab. 2020. PMID: 32250530

5

American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations.

Sasson C, Eckel R, Alger H, Bozkurt B, Carson A, Daviglus M, Deedwania P, Kirley K, Lamendola C, Nguyen M, Rajgopal Singh R, Wang T, Sanchez E. Sasson C, et al. Among authors: lamendola c. J Am Heart Assoc. 2018 Aug 7;7(15):e009271. doi: 10.1161/JAHA.118.009271. J Am Heart Assoc. 2018. PMID: 30371251 Free PMC article. No abstract available.

6

Access to Innovative Medicine: A Preventive Cardiovascular Nurses Association Position Statement to Reduce the Barriers.

Lamendola C, Champagne MA, Nelson Worel J, Coke LA. Lamendola C, et al. J Cardiovasc Nurs. 2018 May/Jun;33(3):199-201. doi: 10.1097/JCN.0000000000000492. J Cardiovasc Nurs. 2018. PMID: 29634645 No abstract available.

7

The relationship between insulin resistance and dyslipidaemia in cigarette smokers.

Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM. Farin HM, et al. Among authors: lamendola c. Diabetes Obes Metab. 2007 Jan;9(1):65-9. doi: 10.1111/j.1463-1326.2006.00574.x. Diabetes Obes Metab. 2007. PMID: 17199720

8

Dietary weight loss in insulin-resistant non-obese humans: Metabolic benefits and relationship to adipose cell size.

McLaughlin T, Abbasi F, Lamendola C, Yee G, Carter S, Cushman SW. McLaughlin T, et al. Among authors: lamendola c. Nutr Metab Cardiovasc Dis. 2019 Jan;29(1):62-68. doi: 10.1016/j.numecd.2018.09.014. Epub 2018 Oct 11. Nutr Metab Cardiovasc Dis. 2019. PMID: 30497926 Free PMC article. Clinical Trial.

9

Hypertriglyceridemia and low high-density lipoprotein: risks for coronary artery disease?

Lamendola C. Lamendola C. J Cardiovasc Nurs. 2000 Jan;14(2):79-90. doi: 10.1097/00005082-200001000-00009. J Cardiovasc Nurs. 2000. PMID: 10653278 Review.

10

Comparison of the association with sleep apnoea of obesity versus insulin resistance.

Liu A, Ariel D, Lamendola C, Kim SH, Abbasi F, Cardell J, Tomasso V, Mojaddidi H, Grove K, Kushida CA, Reaven GM. Liu A, et al. Among authors: lamendola c. Eur Respir J. 2015 Dec;46(6):1829-32. doi: 10.1183/13993003.01087-2015. Epub 2015 Sep 24. Eur Respir J. 2015. PMID: 26405296 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results